title: [Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report].
authors.forename: Azucena
authors.initials: A
authors.lastname: Rodríguez-Guardado
authors.forename: Montserrat
authors.initials: M
authors.lastname: Tuset
authors.forename: Victor
authors.initials: V
authors.lastname: Asensi
authors.forename: José M
authors.initials: JM
authors.lastname: Miró
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate; D014355:Chagas Disease / Q000150:complications / Q000188:drug therapy*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D009593:Nitroimidazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009842:Oligopeptides / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D063065:Organophosphonates / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D010239:Paraguay / Q000208:ethnology; D011725:Pyridines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D011760:Pyrrolidinones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000068898:Raltegravir Potassium; D019438:Ritonavir / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D013030:Spain; D000068698:Tenofovir; D014344:Trypanocidal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015215:Zidovudine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D009593:Nitroimidazoles; D009842:Oligopeptides; D063065:Organophosphonates; D011725:Pyridines; D011760:Pyrrolidinones; D014344:Trypanocidal Agents; D019259:Lamivudine; D000068898:Raltegravir Potassium; D015215:Zidovudine; D000069446:Atazanavir Sulfate; D000068698:Tenofovir; D000225:Adenine; D019438:Ritonavir; C009999:benzonidazole
vernacular_title: Infección combinada por virus de la inmunodeficiencia humana y enfermedad de Chagas tratada satisfactoriamente con benznidazol y una pauta de tratamiento antirretroviral basada en raltegravir: descripción de un caso.